Circle Health Services is a licensed substance use treatment provider in Cleveland, OH, listed in the SAMHSA treatment directory. Outpatient care is offered, so clients can keep living at home between scheduled sessions. Buprenorphine (Suboxone) is offered to reduce opioid cravings and lower relapse and overdose risk. Naltrexone is used to support recovery from opioid or alcohol use disorder. The program treats co-occurring mental health conditions alongside addiction. The facility reports accepting Medicaid. Private health insurance is accepted. It serves children/adolescents, young adults, adults.
Availability and current services change often. Call (888) 470-5244
and we will help you confirm openings, insurance, and next steps.
Levels of care
OutpatientOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatment
Type of care
Substance use treatmentTreatment for co-occurring disorders plus serious mental illness (SMI) in adultsTreatment for co-occurring disorders plus serious emotional disturbance (SED) in children
Medications
Buprenorphine used in TreatmentNaltrexone used in Treatment
Payment accepted
Federal, or any government funding for substance use treatment programsMedicareMedicaidPrivate health insuranceCash or self-paymentSAMHSA funding/block grants
Ages served
Children/AdolescentsYoung AdultsAdultsSeniors
Accreditation
State substance use treatment agencyState mental health departmentState department of healthThe Joint CommissionFederally Qualified Health Center
Free & confidential, 24/7
Not sure which program fits? Talk it through with someone who can help.
OutpatientResidential/24-hour residentialOutpatient day treatment or partial hospitalizationFederal, or any government funding for substance use treatment programsMedicaid
OutpatientResidential/24-hour residentialOutpatient day treatment or partial hospitalizationFederal, or any government funding for substance use treatment programsMedicare
2475 East 22nd Street, 4th Floor, Cleveland, OH 44115
OutpatientIntensive outpatient treatmentOutpatient methadone/buprenorphine or naltrexone treatmentFederal, or any government funding for substance use treatment programsMedicare